Chemical Restraints & Unnecessary Psychotropic Medications
Cited for F605? Here's what surveyors were looking for, how serious it tends to be, and how to structure a Plan of Correction that holds up.
What the regulation says
What F605 actually means
F605 is where oversight of psychotropic medications and chemical restraints now lives, after CMS relocated it here from the old F758. The core question is simple and strict: is this medication treating a documented medical symptom, or is it being used for discipline or staff convenience? A psychotropic without an adequate clinical indication, without a real diagnosis behind it, or without any attempt to reduce the dose over time reads to a surveyor as a chemical restraint. If you were cited as F758 in the past, this is the current tag for the same issue.
What surveyors check
Whether every psychotropic has an adequate clinical indication and a supporting diagnosis, whether non-pharmacological approaches were tried first, whether PRN psychotropic time limits are honored, and whether gradual dose reduction (GDR) has been attempted and documented unless clinically contraindicated. They also look at monitoring for effectiveness and side effects, and informed consent. The pattern they test is whether the medication is genuinely treating a symptom or managing behavior for convenience.
What most often triggers it
- Antipsychotic used without an adequate indication or supporting diagnosis
- No gradual dose reduction attempted or documented
- PRN psychotropic continued beyond the allowed time limit without reevaluation
- Non-pharmacological interventions not tried or not documented
- No monitoring for target symptoms or adverse effects
How serious is it? Scope & severity
F605 can be serious. A psychotropic used as a chemical restraint without clinical justification is frequently cited at actual harm (G) and can reach Immediate Jeopardy (J/K/L) when the use poses a serious risk to the resident. Lower-severity D to F citations occur for documentation and GDR gaps that have not yet produced harm.
The CMS scope & severity grid runs from an isolated no-harm gap (A) up through widespread Immediate Jeopardy (L). The level a surveyor assigns drives how urgent and far-reaching your Plan of Correction must be.
Example citation
How to write the Plan of Correction
(1) Review the cited resident's regimen with the provider: confirm indication, attempt GDR or discontinue as clinically appropriate, and document. (2) Identify scope: audit all residents on psychotropics for indication, diagnosis, GDR, and monitoring. (3) Systemic change: educate providers and staff on indication requirements, GDR expectations, PRN limits, and non-pharmacological alternatives. (4) Monitoring: pharmacy and nursing audit psychotropic use on a defined schedule through QAPI.
Cited for F605? Draft your Plan of Correction now.
Upload your Form 2567 and EasyPOC generates a tailored, CMS-aligned Plan of Correction in minutes.
Upload your citation →Need the policy behind it? Freedom from Abuse, Neglect, and Exploitation policies & procedures →Common questions
What is F605?+−
The CMS tag for chemical restraints, under 42 CFR §483.12(a)(2), which now also covers unnecessary psychotropic medication requirements relocated from the former F758.
Is F605 the same as F758?+−
F605 is the current tag for psychotropic and chemical-restraint concerns; the psychotropic requirements were moved here from F758 in the 2025 revision.
What most commonly triggers it?+−
Psychotropics without adequate indication or diagnosis, and no documented gradual dose reduction.
How do you respond?+−
Reassess the regimen with the provider, audit all psychotropic use, educate on indication and GDR, and monitor through QAPI.
Related tags
This page is a compliance reference and does not constitute legal or clinical advice.